Trials / Completed
CompletedNCT01989975
CareLink Connect - Technical Evaluation Study
A Multi-center, Non-randomized Study in Subjects With Diabetes Mellitus Treated With Sensor-Augmented Pump Therapy to Evaluate the Performance and Safety of CareLink Connect Transferring Pump Data to Web Connected Devices Via CareLink
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the performance, patient satisfaction and safety of connectivity gateway device CareLink Connect, transferring CGM (Continuous Glucose Monitoring) data from a VEO insulin pump to CareLink online (every 5th minute) and thereby making it available for patients or Care Partners individual web connected devices such as smartphones, tablets and PCs.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2013-11-21
- Last updated
- 2019-02-21
- Results posted
- 2019-02-21
Locations
2 sites across 2 countries: Denmark, Netherlands
Source: ClinicalTrials.gov record NCT01989975. Inclusion in this directory is not an endorsement.